XPH logo

XPH State Street SPDR S&P Pharmaceuticals ETF

New York Stock Exchange Arca · Asset Management · Financial Services

$70.46
-0.52 (-0.73%)

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of…

Price

No data yet.

Signal Score (90d)

80
80
Aug 17Aug 17

Quote

Day Range
$69.83 – $70.72
52-Week Range
$45.80 – $71.13
Volume
$80.9K
Market Cap
$284.16M
50-Day Avg
$66.06
200-Day Avg
$58.14
Prev Close
$70.98
Open
$69.84

Valuation & Ratios

P/E Ratio
EPS
P/B Ratio
P/S Ratio
Debt/Equity
Current Ratio
Dividend Yield
Gross Margin

Returns & Efficiency

Return on Equity
Return on Assets
FCF Yield
EV/EBITDA

Social Signal Score

30
5d
31
1 mentions
30d
30
1 mentions
60d
30
1 mentions
90d
30
1 mentions
news: 1

Valuation

XPHhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsfool.com·5h ago·Negative

    XPH vs PJP: Which Pharma ETF Offers Better Value The State Street SPDR S&P Pharmaceuticals ETF offers a significantly lower expense ratio of 0.35% compared to the Invesco Pharmaceuticals ETF. The Invesco Pharmaceuticals ETF provides a more concentrated portfolio of 29 stocks and lower price volatility as measured by beta.

    View source ↗